From the program: Life Sciences Acquisitions and Divestitures: Special Considerations
Released on: Apr. 23, 2015
Taken from the briefing Life Sciences Acquisitions and Divestitures: Special Considerations recorded April, 2015 in New York.
Whether you are acquiring a company or its assets or divesting a portion of your business, if you are involved in mergers and acquisitions relating to pharmaceutical products, biologics, medical devices, diagnostics or similar assets, it is important to understand the products, their regulatory environment, the ...